Bioniq, used by Manchester United & NBA stars, raises Series B round

Quick Summary:

Bioniq has raised £11.5 million in Series B funding for its personalised supplements based on blood biomarker data.

It will focus on global laboratory network integrations; market, operational and human resources expansion in the US and the Middle East; and implementing a corporate platform for medical, wellness and athletic institutions.

It has since become the product of choice for many of the world’s top athletes, including Manchester United’s Diogo Dalot and former NBA All-Star Andrei Kirilenko, who have used Bioniq for years to optimise their micronutrient levels and enhance performance and recovery.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Author / Journalist: Jonathan Symcox

Category: InvestingBusiness

Markets: United Kingdom

Topics: Investment HealthTech

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-07-17 @ 07:27:00 (13 hours ago)

News Timezone: GMT +8:00

News Source URL: businesscloud.co.uk

Language: English

Article Length: 554 words

Reading Time: 4 minutes read

Sentences: 17 lines

Sentence Length: 33 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © BusinessCloud

News ID: 21662111

View Article Analysis

About BusinessCloud

Main Topics: InvestingBusiness

Official Website: businesscloud.co.uk

Update Frequency: 3 posts per day

Year Established: 2016

Headquarters: United Kingdom

News Last Updated: 1 days ago

Coverage Areas: United Kingdom

Ownership: Independent Company

Publication Timezone: GMT +8:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #61

Publisher Details

Frequently Asked Questions